Population-based analysis of oral and oropharyngeal carcinoma: Changing trends of histopathologic differentiation, survival and patient demographics

2010 ◽  
Vol 120 (11) ◽  
pp. 2203-2212 ◽  
Author(s):  
Vikas Mehta ◽  
Guo-Pei Yu ◽  
Stimson P. Schantz
Keyword(s):  
Population Based ◽  
Oropharyngeal Carcinoma ◽  
Patient Demographics ◽  
Changing Trends ◽  
Oral And Oropharyngeal Carcinoma

Outcomes and xerostomia after postoperative radiotherapy for oral and oropharyngeal carcinoma

Head & Neck ◽  
2014 ◽  
pp. n/a-n/a
Author(s):  
Zhong-He Wang ◽  
Chao Yan ◽  
Zhi-Yuan Zhang ◽  
Chen-Ping Zhang ◽  
Hai-Sheng Hu ◽  
...  
Keyword(s):  
Postoperative Radiotherapy ◽  
Oropharyngeal Carcinoma ◽  
Oral And Oropharyngeal Carcinoma

Impact of treatment on quality of life for oral and oropharyngeal carcinoma

2009 ◽  
Vol 38 (10) ◽  
pp. 1052-1058 ◽  
Author(s):  
P. Infante-Cossio ◽  
E. Torres-Carranza ◽  
A. Cayuela ◽  
E. Hens-Aumente ◽  
P. Pastor-Gaitan ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oropharyngeal Carcinoma ◽  
Oral And Oropharyngeal Carcinoma

Validity of sentinel node biopsy in early oral and oropharyngeal carcinoma

2018 ◽  
Vol 46 (10) ◽  
pp. 1748-1752 ◽  
Author(s):  
C.G.U. Riese ◽  
J.-A. Karstadt ◽  
A. Schramm ◽  
S. Güleryüz ◽  
G. Dressel ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Oropharyngeal Carcinoma ◽  
Node Biopsy ◽  
Oral And Oropharyngeal Carcinoma

Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer

2011 ◽  
Vol 29 (24) ◽  
pp. 3255-3262 ◽  
Author(s):  
Thomas A. Abrams ◽  
Rick Brightly ◽  
Jianbin Mao ◽  
Gregory Kirkner ◽  
Jeffrey A. Meyerhardt ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Adjuvant Chemotherapy ◽  
Adjuvant Therapy ◽  
Performance Status ◽  
Population Based ◽  
Stage Ii ◽  
Patient Demographics ◽  
Cancer Care Facilities ◽  
Provider Characteristics ◽  
Resected Stage

Purpose Previous studies have examined predictors for initiation of adjuvant chemotherapy in stages II and III colon cancer. However, little is known regarding the use of specific chemotherapy regimens or treatment duration. Patients and Methods We studied treatment records for 2,560 patients with stage II or III colon cancer who received adjuvant chemotherapy between January 2004 and April 2010 at US cancer care facilities participating in a nationwide, commercially available chemotherapy order entry system that captures patient demographics, stage, and details of chemotherapy treatment. Multivariate analyses of prospectively recorded patient and provider characteristics identified predictors of specific therapeutic approaches. Results The addition of oxaliplatin to fluoropyrimidine-based adjuvant therapy increased during the study period (P trend < .001), and this combination represented 78% and 90% of adjuvant chemotherapy in stage II or III disease, respectively, by 2007. Older patients, those with diminished performance status, and those treated in a private practice setting were significantly less likely to receive oxaliplatin. Thirty percent of patients discontinued adjuvant therapy after less than 3 months. Older age, oxaliplatin-containing therapy, and receipt of treatment from a physician with a low volume of patients were each independently associated with premature discontinuation. Six percent of patients received bevacizumab as part of their adjuvant regimen. Conclusion After 2004, oxaliplatin and fluoropyrimidine-based therapy rapidly became the predominant adjuvant treatment for both stage II and stage III colon cancer in this large US cohort. Both increasing patient age and lower volume of an oncologist's practice were associated with early termination of adjuvant therapy.

Expression of hMSH2 correlates with in vitro chemosensitivity to CDDP cytotoxicity in oral and oropharyngeal carcinoma

1998 ◽  
Vol 132 (1-2) ◽  
pp. 37-44 ◽  
Author(s):  
Shigeharu Fujieda ◽  
Nobuyuki Tanaka ◽  
Hiroshi Sunaga ◽  
Ichiro Noda ◽  
Chizuru Sugimoto ◽  
...  
Keyword(s):  
Oropharyngeal Carcinoma ◽  
In Vitro Chemosensitivity ◽  
Oral And Oropharyngeal Carcinoma

Evaluation of Immunohistochemical Expression of p16 and Presence of Human Papillomavirus in Oral and Oropharyngeal Carcinoma

2014 ◽  
Vol 25 (1) ◽  
pp. 210-214 ◽  
Author(s):  
Ana Luíza Laguardia Cantarutti ◽  
Lais Papini Fernandes ◽  
Marina Vaz de Lima Fullin Saldanha ◽  
Ana Elizia Mascarenhas Marques ◽  
Leonora Maciel de Souza Vianna ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Oropharyngeal Carcinoma ◽  
Immunohistochemical Expression ◽  
Oral And Oropharyngeal Carcinoma

scholarly journals Karyoanomalic frequency assay during radiation therapy – A promising marker in the prognosis of oral and oropharyngeal carcinoma

2021 ◽  
Vol 10 (12) ◽  
pp. 4548
Author(s):  
KumarSatish Ravi ◽  
NB Pushpa ◽  
Sanjeev Kishore ◽  
Sohinder Kaur ◽  
Vandana Mehta ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Oropharyngeal Carcinoma ◽  
Oral And Oropharyngeal Carcinoma
Sign in / Sign up

Export Citation Format

Share Document